Skip to main content
Log in

On the fate of furosemide in man

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

35S-furosemide was administered orally (n=7) or i.v. (n=2) to healthy subjects. The average gastrointestinal uptake estimated by comparison of the urinary recovery of label and the areas under the plasma curves after the two routes of administration was 65%. The half life of radioactivity in the plasma after oral35S-furosemide was 90 ± 17 min (estimated on the slope between 2 and 6 h); the corresponding figure after35S-furosemide i.v. was 47–53 min (slope 0.5–4 h). There was probably a slower phase after 4–6 h. Fractionation of labelled material in urine from two subjects demonstrated that approximately two thirds of the label recovered at 24 h had the same chromatographic properties as furosemide. A major part of the metabolite(s) was probably furosemide glucuronide. There was no evidence that 4-chloro-5-sulfamoylanthranilic acid was formed in man. The total urinary recovery of label (5–7 d) after oral and intravenous administration was 55.1±3.2 (mean±SD) and 82–84%, respectively. After35S-furosemide i.v., 6–9% of the label was recovered in faeces, and it could not be accounted for solely by biliary excretion of furosemide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Beermann B., Hellström, K., Rosén, A.: Gastrointestinal absorption of certain anti-cholinergic drugs. Europ. J. clin. Pharmacol.5, 87–92 (1972)

    Google Scholar 

  • Beermann, B.: On the fate of orally administered3H-lanatoside C in man. Europ. J. clin. Pharmacol.5, 11–18 (1972)

    Google Scholar 

  • Bray, G.B.: A simple efficient liquid scintillator for counting aqueous solutions in liquid scintillation counter. Ann. Biochem. exp. Med.1, 279–285 (1960)

    Google Scholar 

  • Calesnick, B., Christensen, J.A., Richter, M.: Absorption and excretion of furosemide-S35 in human subjects (31391). Proc. Soc. exp. Biol. (N.Y.)123, 17–22 (1966)

    Google Scholar 

  • Cutler, R.E., Forrey, A.W., Christopher, T.B., Kompel, B.M.: Pharmacokinetics of furosemide in normal subjects and functionally anephric patients. Clin. Pharmacol. Ther.15, 588–596 (1974)

    Google Scholar 

  • Hajdù P., Häussler, A.: Untersuchungen mit dem Salidiureticum 4-chlor-N (2-furylmethyl)-5-sulfamyl-antranilsäure. Arzneimittel-Forsch.14, 709–710 (1964)

    Google Scholar 

  • Häussler, A., Wicha, H.: Untersuchungen mit dem Salidiureticum 4-Chlor-N-(2-furylmethyl)-5-sulfamyl-anthranilsäure. Arzneimittel-Forsch.15, 81–83 (1965)

    Google Scholar 

  • Kelly, M.R., Cutler, R.E., Forrey, A.W., Kimpel, B.M.: Pharmacokinetics of orally administered furosemide. Clin. Pharmacol. Ther.15, 178–186 (1974)

    Google Scholar 

  • Kindt, H., Schmid, E.: Über die Harnausscheidung von Furosemid bei Gesunden und Kranken mit Lebercirrhose. Pharmacol. Clin.2, 221–226 (1970)

    Google Scholar 

  • Lindström, B., Molander, M.: Gaschromatographic determination of furosemide in plasma using an extractive alkylation technique and an electron capture detector. J. Chromatogr.101, 219–221 (1974)

    Google Scholar 

  • Rupp, W., Hajdú, P.: Pharmacokinetics and pharmacodynamics of a diuretic agent. In: Pharmacological and clinical significance of pharmacokinetics. (Ed. H.J. Dengler) pp. 105–111, Stuttgart-New York: F.K. Schattauer Verlag 1970

    Google Scholar 

  • Rupp, W., Heidland, A., Hajdù, P. and Neuhans, G.: Pharmakokinetik von Furosemid bei normaler und eingeschränkter Nierenfunktion. In 4. Freiburger Tagung über Nephrologie 1970, Stuttgart: Thieme, pp. 207–213, 1970

    Google Scholar 

  • Rupp, W., Zapf, R.M.: Beispiele zur Phase I: Diuretika. Arzneimittel-Forsch.23, 1665–1668 (1973)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beermann, B., Dalén, E., Lindström, B. et al. On the fate of furosemide in man. Eur J Clin Pharmacol 9, 57–61 (1975). https://doi.org/10.1007/BF00613429

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00613429

Key words

Navigation